Loading
institutionsInstitution
Hospital Universitari i Politècnic La Fe
Valencia's flagship public hospital, with a haematology department that shaped the treatment of acute promyelocytic leukaemia through the PETHEMA group.
Also called: Hospital La FeIIS La Fe
Overview
La Fe is the largest hospital complex of the Valencian region and hosts the IIS La Fe research institute. Its haematology department, long led by Miguel Ángel Sanz, designed the PETHEMA protocols that established risk-adapted all-trans retinoic acid and anthracycline therapy for acute promyelocytic leukaemia and remains a reference for acute leukaemias and transplantation within Spain's PETHEMA cooperative group. The hospital runs a large medical oncology service, paediatric oncology, radiotherapy including stereotactic programmes, a nuclear medicine and PET unit and an early-phase trials unit. It is a regional hub for molecular diagnostics and hereditary cancer counselling.
Location
Valencia, ES
Type
hospital · Universitat de València
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#265 · 24 points (0 Newsweek + 0 NCI + 24 from 12 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-15.
Matched to Hospital Universitari i Politècnic La Fe, including child institutions. 416 works · 3,394 citations · 64% open access · 16% clinical trials · 1% reviews.
Oncology works per year
832022
912023
882024
842025
702026
Most works
- Jaime Sanz34 works
- Óscar Juan30 works
- Manuel Guerreiro26 works
- Matteo Frasson22 works
- Blas Flor‐Lorente21 works
- Pere Barba21 works
- Mi Kwon21 works
- Rafael Hernani21 works
- Lucía López‐Corral19 works
- Gloria Iacoboni18 works
Most cited
- Acute leukaemia (PETHEMA)
- Transplantation
- Paediatric oncology
- Radiotherapy
- Molecular diagnostics
José Luis Poveda Andrés
Gerente (Chief Executive), Hospital Universitari i Politècnic La Fe, Valencia
Hospital managementHealth services management
Chief executive (Gerente) of Hospital Universitari i Politècnic La Fe in Valencia, one of Spain's largest public university hospitals.
Miguel A. Sanz
Haematologist, Hospital Universitari i Politècnic La Fe, Valencia
Acute promyelocytic leukaemiaRisk-adapted therapyPETHEMA trials
Spanish haematologist who led the PETHEMA trials that tailored acute promyelocytic leukaemia treatment to relapse risk, and who chaired the European LeukemiaNet recommendations for the disease.
Similar pages
- InstitutionRamathibodi Hospital, Mahidol University
Shares Allogeneic (off-the-shelf) cell therapy, Germline (hereditary) testing, Acute lymphoblastic leukaemia, Acute myeloid leukaemia.
- InstitutionKing Hussein Cancer Center
Shares Allogeneic (off-the-shelf) cell therapy, PET/CT, Germline (hereditary) testing, Acute lymphoblastic leukaemia.
- InstitutionHamad Medical Corporation / National Center for Cancer Care and Research
Shares Allogeneic (off-the-shelf) cell therapy, Germline (hereditary) testing, Acute myeloid leukaemia, HR-positive / HER2-negative breast cancer.
- PersonStephen J. Forman
Shares Allogeneic (off-the-shelf) cell therapy, Acute lymphoblastic leukaemia, Acute myeloid leukaemia.
- InstitutionKing Faisal Specialist Hospital and Research Centre
Shares Allogeneic (off-the-shelf) cell therapy, Germline (hereditary) testing, Acute lymphoblastic leukaemia, HR-positive / HER2-negative breast cancer.
- CompanyAllotera Therapeutics (formerly Wugen)
Shares Allogeneic (off-the-shelf) cell therapy, Acute lymphoblastic leukaemia, Acute myeloid leukaemia.
- InstitutionTawam Hospital
Shares Allogeneic (off-the-shelf) cell therapy, Acute lymphoblastic leukaemia, HR-positive / HER2-negative breast cancer, Colorectal cancer.
- InstitutionTata Medical Center, Kolkata
Shares Allogeneic (off-the-shelf) cell therapy, Acute lymphoblastic leukaemia, Acute myeloid leukaemia, HR-positive / HER2-negative breast cancer.